Five major drug companies are still in the hunt to acquire Amylin (AMLN) as the auction enters...
Five major drug companies are still in the hunt to acquire Amylin (AMLN) as the auction enters its final stage, Reuters reports, with final bids expected to start coming in at the end of the week. The runners and riders are Novartis (NVS), Sanofi (SNY), Bristol Myers (BMY), AstraZenica (AZN) and Merck (MRK). (See also)
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs